Alnylam Pharmace. sell fenjal
Start price
24.06.24
/
50%
€210.70
Target price
24.06.25
-
Performance (%)
8.16%
End price
01.07.24
€227.90
Summary
This prediction ended on 01.07.24 with a price of €227.90. The SELL prediction by fenjal shows the price for Alnylam Pharmace. slightly increased by 8.16% during the runtime of the prediction. fenjal has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Alnylam Pharmace. | 11.008% | 11.008% | 19.967% |
| iShares Core DAX® | 0.388% | 0.145% | 10.959% |
| iShares Nasdaq 100 | 1.307% | -2.548% | -0.608% |
| iShares Nikkei 225® | -0.463% | 6.891% | 26.748% |
| iShares S&P 500 | 1.314% | -1.163% | -0.036% |
Comments by fenjal for this prediction
In the thread Alnylam Pharmace. diskutieren
Sell Alnylam Pharmace.